amiodarone has been researched along with procainamide in 144 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 65 (45.14) | 18.7374 |
1990's | 28 (19.44) | 18.2507 |
2000's | 27 (18.75) | 29.6817 |
2010's | 23 (15.97) | 24.3611 |
2020's | 1 (0.69) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Budriesi, R; Chiarini, A; Ioan, P; Sparatore, F; Tasso, B; Terranova, E; Ugenti, MP; Vazzana, I | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Budriesi, R; Chiarini, A; Ioan, P; Micucci, M; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Vazzana, I | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Sen, S; Sinha, N | 1 |
Bruno, C; Budriesi, R; Carbonara, R; Carocci, A; Catalano, A; Colabufo, NA; Conte Camerino, D; De Palma, A; Desaphy, JF; Di Mola, A; Franchini, C; Ghelardini, C; Lentini, G; Perrone, MG | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jewitt, DE | 1 |
Theisen, K | 1 |
Donaldson, RM | 1 |
Koch-Weser, J | 1 |
Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA | 1 |
Fananapazir, L; McAreavey, D | 1 |
Huang, SK; Liu, XQ | 1 |
Chen, F; Klitzner, TS; Wetzel, GT | 1 |
Honerjäger, P; Schmidt, G | 1 |
Fomina, IG; Iankin, VV | 1 |
Scheinman, MM | 1 |
Mazur, NA; Shestakova, NV | 1 |
Kurbanov, RD | 1 |
Bandyopadhyay, S; Klaunig, JE; Somani, P | 1 |
Buxton, AE; Josephson, ME; Marchlinski, FE; Vaitkus, PT | 1 |
Roden, DM | 2 |
Oleĭnikov, VE; Tatarchenko, IP; Zhivotovskaia, GG | 1 |
Bigman, O; Miller, B; Rubenfire, M; Skupin, A | 1 |
Yamaguchi, I | 1 |
Somberg, J | 1 |
Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Roy, D | 1 |
Echt, DS; Roden, DM; Woosley, RL | 1 |
Andersson, KE; Wettrell, G | 1 |
Morganroth, J; Nestico, PF | 2 |
Huang, SK; Marcus, FI | 1 |
Light, RT; Onrot, J; Robertson, D; Robertson, RM; Tantengco, MV | 1 |
Knowlton, PW; Liu, LL; Svensson, CK | 1 |
Casta, A; Donner, RM; Dunn, JM; Mehta, AV; Sacks, EJ; Sanchez, GR | 1 |
Bloom, RB; Buxton, AE; Gottlieb, CD; Josephson, ME; Kindwall, KE; Marchlinski, FE; Miller, JM; Rosenthal, ME | 1 |
Horowitz, LN; Kay, HR; Kutalek, SP; Rae, AP; Spielman, SR | 1 |
Heger, JJ; Miles, WM; Prystowsky, EN; Windle, J | 1 |
Cook, TS; DiMarco, JP; Nygaard, TW; Sellers, TD | 1 |
Nguyen, PT; Scheinman, MM; Seger, J | 1 |
Buxton, AE; Flores, BT; Josephson, ME; Marchlinski, FE; Miller, JM; Vassallo, JA | 1 |
Klein, H | 1 |
Feld, G; Hendrickson, J; Heng, MK; Intarachot, V; Nademanee, K; Singh, BN; Yale, C | 1 |
Stewart, PA; Wladimiroff, JW | 1 |
Sanna, G | 1 |
Brugada, P; Den Dulk, K; Stevenson, W; Waldecker, B; Wellens, HJ; Zehender, M | 1 |
Buxton, AE; Josephson, ME | 1 |
Buchanan, D; Crawford, F; Gillette, PC; Zinner, A | 1 |
Baerman, JM; DiCarlo, LA; Krol, RB; Morady, F | 1 |
Greenspan, AM; Horowitz, LN; Rae, AP; Sokoloff, NM; Spielman, SR; Webb, CR | 1 |
Gang, ES; Hamer, A; Mandel, WJ; Oseran, DS; Peter, T; Rosenthal, ME | 1 |
De Thomatis, M | 1 |
Opie, LH | 1 |
Reid, PR; Vlay, SC | 1 |
Hillis, WS; Whiting, B | 1 |
Prystowsky, EN | 1 |
Somberg, JC | 1 |
Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D | 1 |
Correia, MJ; d'Almeida, VC; da Costa, FL; Mourão, L; Ribeiro, C; Tuna, JL | 1 |
Markov, KV; Sapozhnikov, AA | 1 |
Kerr, CR; Levick, CE; Mizgala, HF | 1 |
Pollak, S; Walter, PF | 1 |
Rosen, MR; Wit, AL | 1 |
Block, PJ; Winkle, RA | 1 |
Kates, RE | 1 |
Bittencourt, LA; Coelho, OR; Jorge, PA; Pinho, C | 1 |
Guillermo-Cal, L; Serpa, M; Warlet, RV; Xavier, SS; Zielinsky, P | 1 |
Abdollah, H; Brugada, P; Wellens, HJ | 1 |
Chenzbraun, A; Cohen, AM; Keren, A; Loebel, H; Stern, S; Tzivoni, D; Zahavi, I | 1 |
Graham, EL; Greene, HL; Saal, AK; Sears, GK; Werner, JA | 1 |
Cinca, J; Figueras, J; Gutierrez, L; Montoyo, J; Rius, J; Valle, V | 1 |
Golitsyn, SP; Grosu, AA; Smetnev, AS; Sokolov, SF | 1 |
Cho, YW; Kuemmerle, HP; Singh, BN | 1 |
Botvinick, EH; Hess, D; Morady, F; Scheinman, MM; Shen, EN; Sung, RJ | 1 |
Braat, S; Brugada, P; Dassen, WR; Gorgels, AP; Wellens, HJ | 1 |
Lukoshevichiute, AI; Reĭngardene, DI | 1 |
Coelho, A; Rosen, KM; Strasberg, B; Welch, WJ | 1 |
Chiavarelli, V; Milazzotto, F; Vajola, SF | 1 |
Bär, FW; Brugada, P; Dassen, WR; Farré, J; Vanagt, EJ; Wellens, HJ | 1 |
Dreifus, LS; Kaplinsky, E; Kmetzo, JJ; Michelson, EL; Naito, M | 1 |
Cui, G; Sager, P; Sen, L; Singh, BN; Uppal, P | 1 |
Amato, RV; Bellotti, G; César, LA; D'Avila, AL; Ferreira, JF; Pamplona, D; Pfeferman, E; Scanavacca, M; Serrano, CV; Sosa, EA | 1 |
Alvarez, L; Escudero, C; Millán, I; Torralba, A | 1 |
Abu-Much, Z; Rafael, C; Rozenfeld, V; Schoham, H; Schwartz, J | 1 |
Follmer, C; Godfrey, R; Pruitt, C; Sager, PT; Uppal, P | 1 |
Bobrov, VA; Bobrova, EV; Galichanskiĭ, IV; Kupnovitskaia, IG; Mikhalkin, IA; Zalesskiĭ, VN | 1 |
Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
Ebihara, Y; Handa, S; Hasegawa, H; Honma, S; Ishida, H; Iwanaga, S; Koyama, T; Shimizu, K; Shinmura, K; Tani, M | 1 |
Chapman, MJ; Cunningham, DN; Moran, JL; O'Fathartaigh, MS; Peisach, AR | 1 |
Chang, MS; Chen, SA; Cheng, CC; Chiang, CE; Chiou, CW; Lee, SH; Tai, CT; Ueng, KC; Wen, ZC | 1 |
Balog, AI; Bezruk, AP; Golovenkin, SE; Matiouchine, GV; Shulman, VA | 1 |
Chang, MS; Chen, SA; Ding, YA; Feng, AN; Kuo, BI; Lee, SH; Tai, CT; Yu, WC | 1 |
Bartashevich, VV; Boldin, VB; Galenko-Iaroshevskiĭ, PA; Khankoeva, AI; Popov, PB; Sirotenko, DV; Uvarov, AV | 1 |
Humphries, JO | 1 |
D'Andrea, A; Ducceschi, V; Iacono, A; Liccardo, B; Santangelo, L; Sarubbi, B | 1 |
Sahu, J; Trohman, RG | 1 |
Olshansky, B | 1 |
Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL | 1 |
Chaudhry, GM; Haffajee, CI | 1 |
Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Spindler, B; Yee, R; Zarnke, K | 1 |
Dorian, P; Pinter, A | 1 |
Kudenchuk, PJ | 1 |
Hashimoto, K; Ishida, Y; Kugiyama, K; Satoh, Y; Sugiyama, A; Yoneyama, M; Yoshida, H | 1 |
Chan, TC; Harrigan, R; Knowlton, KU; Nelson, JA; Pollack, ML | 1 |
Dorian, P; Sarkozy, A | 1 |
Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Yee, R; Zarnke, K | 1 |
Anisimova, VA; Kirillov, OV; Petrov, VI; Spasov, AA | 1 |
Holmes, EC; Samuels, FL; Samuels, LE | 1 |
Chlouverakis, GI; Hamilos, ME; Igoumenidis, NE; Kochiadakis, GE; Marketou, ME; Vardas, PE | 1 |
Lipnitskii, TN; Moroz, VM | 1 |
Joshi, S; Pierce, W; Raiszadeh, F; Steinberg, JS | 1 |
Papadimitriou, D; Papadimitriou, L; Prapa, V; Xanthos, T | 1 |
Trappe, HJ | 1 |
Bar-Cohen, Y; Chang, PM; Moromisato, DY; Silka, MJ | 1 |
deSouza, IS; Ellinor, PT; Marill, KA; Nishijima, DK; Ruskin, JN; Senecal, EL; Setnik, GS; Stair, TO | 1 |
Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C | 1 |
Concannon, C; Li, VH; Li, VY; Mallick, A | 1 |
Goodman, IS; Lu, CJ | 1 |
Birnie, D; Blecher, GE; Borgundvaag, B; Brison, RJ; Clement, CM; Lang, E; Langhan, T; Magee, K; Perry, JJ; Rowe, BH; Stenstrom, R; Stiell, IG; Wells, GA | 1 |
Marceau, F; Parks, A | 1 |
Almendral, J; Arribas, F; Coll-Vinent, B; Del Arco, C; Martín, A; Ortiz, M; Peinado, R | 1 |
Finlay, MC; Schilling, RJ; Specterman, M | 1 |
Koyfman, A; Long, B | 1 |
Chan, HK; Cooper, B; Giordano, J; Harvin, JA; Huebinger, R; Idris, A; Wang, HE | 1 |
33 review(s) available for amiodarone and procainamide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Limitations of present drug therapy of cardiac arrhythmias--a review.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Lidocaine; Procainamide; Quinidine; Verapamil | 1977 |
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
[New anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Humans; Phenethylamines; Procainamide; Propanolamines; Sotalol; Sulfonamides; Survival Rate; Tachycardia | 1992 |
[Mechanisms of interactions of anti-arrhythmia agents during their combined use].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Potassium; Procainamide; Propranolol; Quinidine; Verapamil | 1991 |
[Comparative characteristics of arrhythmogenic effects of anti-arrhythmia agents].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Electrocardiography; Humans; Moricizine; Phenothiazines; Procainamide; Propranolol | 1991 |
[The interaction of antiarrhythmic drugs with other drugs].
Topics: Adrenergic beta-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Digoxin; Drug Interactions; Humans; Lidocaine; Mexiletine; Phenytoin; Procainamide; Quinidine | 1985 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Digitalis; Disopyramide; Drug Interactions; Encainide; Flecainide; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Lidocaine; Liver; Piperidines; Plants, Medicinal; Plants, Toxic; Potassium; Procainamide; Quinidine; Regional Blood Flow; Tocainide | 1986 |
Cardiovascular drugs. I: Antidysrhythmic drugs.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atrial Fibrillation; Benzofurans; Digitalis Glycosides; Disopyramide; Encainide; Female; Humans; Lidocaine; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide | 1984 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
Metabolites of cardiac antiarrhythmic drugs: their clinical role.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Disopyramide; Encainide; Humans; Lidocaine; Piperidines; Procainamide; Quinidine | 1984 |
[Value of drug tests in Wolff-Parkinson-White syndrome].
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; Diagnosis, Differential; Electrocardiography; Humans; Lidocaine; Myocardial Infarction; Procainamide; Quinidine; Verapamil; Wolff-Parkinson-White Syndrome | 1981 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Coronary Artery Bypass; Death, Sudden, Cardiac; Electric Countershock; Humans; Meta-Analysis as Topic; Monitoring, Physiologic; Postoperative Care; Postoperative Complications; Procainamide; Quinidine; Recurrence; Risk Factors; Time Factors | 1998 |
Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Digoxin; Electric Countershock; Flecainide; Humans; Procainamide; Quinidine; Verapamil | 1998 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil | 2000 |
Antiarrhythmic agents and proarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Conduction System; Humans; Procainamide; Sodium Channel Blockers | 2000 |
Intravenous antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Procainamide; Propafenone; Tachycardia, Ventricular | 2001 |
Advanced cardiac life support antiarrhythmic drugs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonary Resuscitation; Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Arrest; Humans; Lidocaine; Life Support Care; Magnesium; Male; Procainamide; Treatment Outcome | 2002 |
Strategies for reversing shock-resistant ventricular fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonary Resuscitation; Electric Countershock; Heart Arrest; Hemodynamics; Humans; Lidocaine; Magnesium; Procainamide; Vasoconstrictor Agents; Vasopressins; Ventricular Fibrillation | 2003 |
Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Coronary Artery Bypass; Digoxin; Diltiazem; Drug Therapy, Combination; Electric Countershock; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Length of Stay; Male; Middle Aged; Postoperative Complications; Procainamide; Retrospective Studies; Treatment Outcome | 2005 |
[Arrhythmias during pregnancy].
Topics: Adenosine; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Humans; Lidocaine; Pregnancy; Pregnancy Complications, Cardiovascular; Procainamide | 2008 |
Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Emergency Service, Hospital; Humans; Male; Procainamide; Tachycardia; Wolff-Parkinson-White Syndrome | 2010 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Evidence-Based Medicine; Humans; Lidocaine; Procainamide; Pyrimidinones; Review Literature as Topic; Sotalol; Tachycardia, Ventricular | 2017 |
17 trial(s) available for amiodarone and procainamide
Article | Year |
---|---|
Prevention of sudden coronary death by chronic antiarrhythmic therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation | 1978 |
[Prospective course of therapy arresting attacks of atrial fibrillation in patients with preexcitation syndromes].
Topics: Adult; Aged; Aged, 80 and over; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Pre-Excitation Syndromes; Procainamide; Propranolol; Quinidine; Time Factors; Verapamil | 1992 |
Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Tachycardia; Time Factors; Ventricular Fibrillation | 1987 |
Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia.
Topics: Adult; Aged; Amiodarone; Death, Sudden; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Ventricles; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide; Quinidine; Risk; Syncope; Tachycardia; Time Factors | 1986 |
Mexiletine: double-blind comparison with procainamide in PVC suppression and open-label sequential comparison with amiodarone in life-threatening ventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmia, Sinus; Benzofurans; Clinical Trials as Topic; Digestive System; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Mexiletine; Middle Aged; Procainamide; Propylamines | 1985 |
[Impressions and certainties concerning the harmful effects of anti-arrhythmic drugs].
Topics: Acetylation; Amiodarone; Anilides; Anti-Arrhythmia Agents; Clinical Trials as Topic; Encainide; Humans; Kinetics; Molecular Biology; Placebos; Procainamide; Quinidine | 1985 |
Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
Topics: Amiodarone; Benzofurans; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Humans; Myocardial Infarction; Oxprenolol; Procainamide; Random Allocation | 1980 |
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Time Factors | 1994 |
[Acute atrial fibrillation in the emergency room. Which is the best drug for a rapid sinus rhythm conversion?].
Topics: Acute Disease; Adult; Aged; Amiodarone; Atrial Fibrillation; Emergencies; Female; Humans; Male; Middle Aged; Procainamide; Quinidine; Sinoatrial Node; Time Factors | 1994 |
The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Topics: Action Potentials; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Heart; Heart Conduction System; Humans; Isoproterenol; Middle Aged; Procainamide; Prospective Studies; Reaction Time; Refractory Period, Electrophysiological; Tachycardia, Ventricular; Ventricular Function | 1994 |
Usefulness of sotalol for life-threatening ventricular arrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Procainamide; Sotalol | 1993 |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; Procainamide; Propafenone; Propranolol; Sotalol; Tachycardia, Supraventricular; Verapamil | 1998 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Digoxin; Drug Administration Routes; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Length of Stay; Male; Pilot Projects; Procainamide; Prognosis; Propafenone; Prospective Studies; Recurrence; Sotalol | 2000 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrioventricular Node; Calcium Channel Blockers; Cardiac Surgical Procedures; Electric Countershock; Female; Heart Rate; Heart Ventricles; Humans; Length of Stay; London; Male; Middle Aged; Pilot Projects; Postoperative Complications; Procainamide; Propafenone; Prospective Studies; Recurrence; Sotalol; Survival Analysis; Treatment Outcome | 2003 |
A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide; Propafenone; Prospective Studies; Single-Blind Method | 2007 |
Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Digoxin; Drug Therapy, Combination; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Procainamide; Time Factors; Treatment Outcome | 2007 |
Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Patient Selection; Procainamide; Tachycardia, Ventricular; Treatment Outcome | 2017 |
95 other study(ies) available for amiodarone and procainamide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Novel quinolizidinyl derivatives as antiarrhythmic agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Electrocardiography; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isometric Contraction; Lidocaine; Muscle, Smooth, Vascular; Myocardial Contraction; Procainamide; Quinidine; Quinolizines; Stimulation, Chemical; Structure-Activity Relationship; Vasodilation | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Electric Stimulation; Guinea Pigs; Heart; Heart Rate; Ileum; In Vitro Techniques; Muscle, Smooth; Myocardial Contraction; Platelet Aggregation Inhibitors; Quinolizidines; Receptor, Muscarinic M2; Stereoisomerism; Structure-Activity Relationship; Vasodilator Agents | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Ataxia; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Caco-2 Cells; Guinea Pigs; Heart; Heart Rate; HEK293 Cells; Humans; Ion Channel Gating; Mexiletine; Mice; NAV1.5 Voltage-Gated Sodium Channel; Permeability; Sodium Channels; Stereoisomerism; Vasodilator Agents | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1978 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digoxin; Disopyramide; Electric Countershock; Humans; Phenytoin; Procainamide; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1979 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1978 |
Suppression of incessant ventricular tachycardia in hypertrophic cardiomyopathy associated with improvement of severe left ventricular dysfunction.
Topics: Adult; Amiodarone; Cardiomyopathy, Hypertrophic; Electrocardiography; Humans; Male; Pacemaker, Artificial; Procainamide; Stroke Volume; Tachycardia, Ventricular; Ventricular Function, Left | 1992 |
[Effects of amiodarone on kinetics of procainamide and its major metabolite disposition in rabbit].
Topics: Acecainide; Amiodarone; Animals; Drug Interactions; Female; Male; Procainamide; Rabbits | 1992 |
Acute effects of amiodarone on sodium currents in isolated neonatal ventricular myocytes: comparison with procainamide.
Topics: Amiodarone; Animals; Animals, Newborn; Cells, Cultured; Heart; Heart Ventricles; Membrane Potentials; Myocardium; Procainamide; Rabbits; Sodium; Sodium Channels; Ventricular Function | 1992 |
Invasive electrophysiologic studies as predictor of sudden death and for treatment of patients with aborted sudden death.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Child; Death, Sudden; Electric Countershock; Electrophysiology; Female; Follow-Up Studies; Heart; Heart Arrest; Humans; Male; Middle Aged; Procainamide; Quinidine; Tachycardia | 1990 |
Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture.
Topics: Amiodarone; Animals; Atenolol; Biomarkers; Cardiotonic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Liver; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Procainamide; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Verapamil | 1990 |
Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
Topics: Amiodarone; Cardiac Pacing, Artificial; Coronary Disease; Electrophysiology; Female; Heart; Humans; Male; Middle Aged; Procainamide; Tachycardia | 1990 |
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Delayed-Action Preparations; Disopyramide; Heart Arrest; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Procainamide; Resuscitation; Tocainide | 1985 |
[Anti-arrhythmic action of combinations of trimecaine with quinidine, novocainamide and cordaron (clinico-experimental study)].
Topics: Acetanilides; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cardiac Complexes, Premature; Dogs; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Procainamide; Quinidine; Trimecaine | 1985 |
Respiratory failure produced by severe procainamide intoxication in a patient with preexisting peripheral neuropathy caused by amiodarone.
Topics: Amiodarone; Humans; Male; Middle Aged; Neuromuscular Junction; Peripheral Nervous System Diseases; Procainamide; Respiratory Insufficiency; Respiratory Muscles | 1988 |
Orthostatic hypotension: clinical spectrum and approach to treatment.
Topics: Adult; Aged; Amiodarone; Disopyramide; Female; Flecainide; Humans; Hypotension, Orthostatic; Lidocaine; Male; Middle Aged; Piperidines; Procainamide; Quinidine; Sympathomimetics; Tocainide | 1986 |
Effect of amiodarone on the disposition of procainamide in the rat.
Topics: Administration, Oral; Amiodarone; Animals; Drug Interactions; Half-Life; Male; Procainamide; Rats; Rats, Inbred Strains | 1988 |
Ectopic automatic atrial tachycardia in children: clinical characteristics, management and follow-up.
Topics: Administration, Oral; Amiodarone; Child; Child, Preschool; Electrocardiography; Electrophysiology; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Monitoring, Physiologic; Procainamide; Tachycardia, Ectopic Atrial; Tachycardia, Supraventricular | 1988 |
Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Cardiac Pacing, Artificial; Drug Combinations; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Refractory Period, Electrophysiological; Tachycardia, Supraventricular | 1988 |
Pharmacokinetic and electrophysiologic interactions of amiodarone and procainamide.
Topics: Aged; Amiodarone; Drug Interactions; Electrocardiography; Female; Heart; Heart Ventricles; Humans; Infusions, Intravenous; Kinetics; Male; Middle Aged; Procainamide; Tachycardia; Ventricular Fibrillation | 1987 |
Adverse reactions to antiarrhythmic drugs during therapy for ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Prospective Studies; Quinidine; Tachycardia; Ventricular Fibrillation | 1986 |
Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval.
Topics: Adolescent; Adult; Aged; Amiodarone; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion; Procainamide; Quinidine; Tachycardia | 1986 |
[Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electric Stimulation; Electrocardiography; Electrophysiology; Female; Heart Ventricles; Humans; Male; Monitoring, Physiologic; Procainamide; Tachycardia; Ventricular Fibrillation | 1985 |
Treatment of fetal cardiac arrhythmias.
Topics: Amiodarone; Arrhythmia, Sinus; Arrhythmias, Cardiac; Chromosome Aberrations; Chromosome Disorders; Diagnosis, Differential; Digoxin; Drug Therapy, Combination; Echocardiography; Edema, Cardiac; Female; Fetal Diseases; Fetal Growth Retardation; Fetal Heart; Gestational Age; Heart Rate; Humans; Karyotyping; Lung; Maternal-Fetal Exchange; Pregnancy; Procainamide; Prognosis; Propranolol; Quinidine; Ultrasonography; Vena Cava, Superior; Verapamil | 1985 |
Importance of modes of electrical termination of ventricular tachycardia for the selection of implantable antitachycardia devices.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Humans; Male; Middle Aged; Pacemaker, Artificial; Procainamide; Prostheses and Implants; Retrospective Studies; Stroke Volume; Syncope; Tachycardia | 1986 |
Role of electrophysiologic studies in identifying arrhythmogenic properties of antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electric Stimulation; Electrophysiology; Heart Arrest; Humans; Procainamide; Prognosis; Quinidine; Tachycardia | 1986 |
Ventricular tachydysrhythmias in near-miss sudden infant death syndrome.
Topics: Amiodarone; Heart Ventricles; Humans; Infant, Newborn; Infusions, Parenteral; Male; Procainamide; Propranolol; Quinidine; Recurrence; Sudden Infant Death; Tachycardia | 1986 |
Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction.
Topics: Adult; Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Heart Conduction System; Heart Ventricles; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Procainamide; Time Factors | 1985 |
Limitations of failure of procainamide during electrophysiologic testing to predict response to other medical therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electric Stimulation; Electrophysiology; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Procainamide; Quinidine; Time Factors | 1985 |
The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Female; Heart Arrest; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Mitral Valve Prolapse; Procainamide; Propafenone; Propiophenones; Propranolol; Risk | 1985 |
[Medical treatment of disturbances of the heart rhythm].
Topics: Ajmaline; Amiodarone; Arrhythmias, Cardiac; Digoxin; Disopyramide; Humans; Procainamide; Propranolol | 1973 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Heart Conduction System; Hemodynamics; Humans; Lidocaine; Mexiletine; Procainamide; Quinidine; Verapamil | 1980 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Echocardiography; Electric Stimulation; Humans; Ischemia; Lidocaine; Myocardial Infarction; Nitrates; Pacemaker, Artificial; Phenytoin; Procainamide; Radionuclide Imaging; Risk | 1982 |
Antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide; Verapamil | 1983 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
[Detection and long-term treatment of ventricular extrasystole in patients with ischemic heart disease].
Topics: Adult; Amiodarone; Cardiac Complexes, Premature; Coronary Disease; Female; Heart Ventricles; Humans; Male; Middle Aged; Procainamide; Time Factors | 1983 |
Failure to pace following high dose antiarrhythmic therapy--reversal with isoproterenol.
Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Drug Therapy, Combination; Electrocardiography; Humans; Isoproterenol; Pacemaker, Artificial; Phenytoin; Procainamide; Tachycardia | 1984 |
Rapid ventricular tachycardia due to His-Purkinje reentry.
Topics: Adult; Aged; Amiodarone; Bundle of His; Cardiac Pacing, Artificial; Electrocardiography; Heart Conduction System; Heart Ventricles; Humans; Lidocaine; Male; Myocardial Infarction; Procainamide; Purkinje Fibers; Tachycardia | 1984 |
[Torsade de pointes induced by anti-arrhythmia agents. Report of 2 cases].
Topics: Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Tachycardia | 1984 |
[Immersion reflex. A new alternative in the initial treatment of paroxysmal atrial tachycardia in infants. Report of a case].
Topics: Amiodarone; Echocardiography; Electrocardiography; Female; Humans; Immersion; Infant; Procainamide; Tachycardia, Paroxysmal | 1984 |
Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
Topics: Ajmaline; Amiodarone; Atrial Fibrillation; Benzofurans; Electrophysiology; Heart; Humans; Isoproterenol; Procainamide; Tachycardia, Paroxysmal; Wolff-Parkinson-White Syndrome | 1983 |
Magnesium therapy for torsades de pointes.
Topics: Aged; Amiodarone; Electrocardiography; Female; Humans; Imipramine; Magnesium Sulfate; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Thioridazine | 1984 |
Effect of amiodarone on serum quinidine and procainamide levels.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Female; Humans; Male; Middle Aged; Procainamide; Prospective Studies; Quinidine | 1984 |
Shortening of ventriculoatrial conduction in patients with left-sided Kent bundles.
Topics: Adult; Amiodarone; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Tachycardia | 1984 |
[Method of evaluating antiarrhythmic therapy in patients with paroxysms of supraventricular tachycardia].
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Evaluation; Electric Stimulation; Female; Humans; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Tachycardia, Paroxysmal; Verapamil | 1984 |
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Propranolol; Tocainide | 1981 |
Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Cardiomyopathies; Catecholamines; Coronary Disease; Electrophysiology; Female; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Procainamide; Propranolol; Tachycardia; Time Factors | 1983 |
Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Benzofurans; Electrophysiology; Female; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Time Factors; Wolff-Parkinson-White Syndrome | 1983 |
Sustained macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Disopyramide; Electrocardiography; Heart Conduction System; Humans; Male; Procainamide; Quinidine; Recurrence; Tachycardia | 1982 |
[Pharmacological therapy and prevention of recurrent ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Bunaftine; Disopyramide; Humans; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Tachycardia | 1981 |
Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.
Topics: Accessory Nerve; Adolescent; Adult; Ajmaline; Amiodarone; Child; Female; Heart Block; Humans; Male; Middle Aged; Neural Conduction; Procainamide; Quinidine; Refractory Period, Electrophysiological; Time Factors; Wolff-Parkinson-White Syndrome | 1980 |
Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Coronary Vessels; Dogs; Lidocaine; Ligation; Perfusion; Procainamide; Ventricular Fibrillation; Verapamil | 1981 |
Electrophysiologic effects of procainamide, mexiletine, and amiodarone on the transplanted heart. Experimental study.
Topics: Amiodarone; Animals; Blood Pressure; Cardiac Output; Dogs; Electrocardiography; Heart Conduction System; Heart Transplantation; Hemodynamics; Mexiletine; Procainamide; Refractory Period, Electrophysiological; Transplantation, Heterotopic | 1995 |
Change of the degree of septal hypertrophy in hypertrophic obstructive cardiomyopathy under procainamide treatment. A case report.
Topics: Aged; Aged, 80 and over; Amiodarone; Bradycardia; Cardiomyopathy, Hypertrophic; Contraindications; Electrocardiography; Female; Follow-Up Studies; Heart Septum; Humans; Procainamide; Propranolol; Ultrasonography | 1995 |
[The optimization of the anti-arrhythmia effect of kordaron and novocainamide by laser biostimulation therapy in a combined program for treating refractory tachyarrhythmias].
Topics: Acupuncture Points; Amiodarone; Blood; Combined Modality Therapy; Evaluation Studies as Topic; Heart Rate; Humans; Laser Therapy; Procainamide; Tachycardia | 1993 |
[Lethal arrhythmias in a patient with coarctation of the aorta and severe heart failure: their control by combination of low dose amiodarone with procainamide for 3 years].
Topics: Administration, Oral; Adult; Amiodarone; Aortic Coarctation; Drug Therapy, Combination; Heart Failure; Humans; Male; Procainamide; Tachycardia, Ventricular | 1993 |
Management of atrial tachyarrhythmias in the critically ill: a comparison of intravenous procainamide and amiodarone.
Topics: Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide; Prospective Studies; Tachycardia | 1993 |
Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Cardiac Catheterization; Cardiac Pacing, Artificial; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Humans; Isoproterenol; Life Tables; Male; Middle Aged; Procainamide; Proportional Hazards Models; Remission, Spontaneous; Tachycardia, Atrioventricular Nodal Reentry; Verapamil; Wolff-Parkinson-White Syndrome | 1996 |
Combined transesophageal left atrial pacing and antiarrhythmic therapy in the treatment of atrial flutter.
Topics: Ambulatory Care; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Function; Cardiac Pacing, Artificial; Combined Modality Therapy; Coronary Disease; Drug Combinations; Electrocardiography; Esophagus; Female; Heart Atria; Heart Rate; Humans; Hypertension; Male; Middle Aged; Procainamide; Remission, Spontaneous | 1996 |
[Correction of the cardiotoxic effect of the anti-arrhythmia agents with befol, sufan, and their combination].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzamides; Benzimidazoles; Cardiotonic Agents; Dibenzazepines; Drug Antagonism; Electrocardiography; Lidocaine; Male; Morpholines; Procainamide; Propranolol; Rats; Rats, Wistar; Succinates; Tryptophan; Verapamil | 1998 |
Drug-induced torsade de pointes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Heart Arrest; Humans; Male; Procainamide; Tachycardia, Ventricular; Torsades de Pointes | 1999 |
Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiovascular Surgical Procedures; Clinical Trials as Topic; Education, Medical, Continuing; Humans; Lidocaine; Postoperative Care; Procainamide; Tachycardia, Ventricular; Ventricular Fibrillation | 1998 |
Comparison of the in vivo electrophysiological and proarrhythmic effects of amiodarone with those of a selective class III drug, sematilide, using a canine chronic atrioventricular block model.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Female; Heart Block; Male; Procainamide; Torsades de Pointes | 2002 |
Electrocardiographic manifestations: wide complex tachycardia due to accessory pathway.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Female; Heart Conduction System; Humans; Procainamide; Tachycardia | 2003 |
[The development and clinical testing of antiarrhythmia drugs of a new chemical class].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzimidazoles; Calcium Channel Blockers; Clinical Trials as Topic; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Verapamil | 2003 |
Simulation of cardiac hypopolarization arrhythmias and evaluation of cardiomyocyte membrane hypopolarization in experimental animals.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Blood Pressure; Cell Membrane; Computer Simulation; Dose-Response Relationship, Drug; Drug Evaluation; Electrocardiography; Female; Heart Arrest, Induced; Hypokalemia; Infusions, Intravenous; Kinetics; Male; Myocytes, Cardiac; Potassium Chloride; Procainamide; Rats; Ventricular Pressure | 2006 |
Antiarrhythmic induced electrical storm in Brugada syndrome: a case report.
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Defibrillators, Implantable; Electrocardiography; Female; Humans; Isoproterenol; Middle Aged; Procainamide; Tachycardia, Ventricular; Vasodilator Agents; Ventricular Fibrillation | 2007 |
Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients.
Topics: Acute Disease; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Injections, Intravenous; Male; Practice Guidelines as Topic; Procainamide; Retrospective Studies; Secondary Prevention; Tachycardia, Supraventricular; Treatment Outcome; Young Adult | 2010 |
Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Drug Administration Schedule; Electrocardiography; Emergency Treatment; Female; Hospitals, Urban; Humans; Hypotension; Infusions, Intravenous; Linear Models; Logistic Models; Male; Massachusetts; Middle Aged; Multivariate Analysis; New York; Practice Guidelines as Topic; Procainamide; Retrospective Studies; Single-Blind Method; Tachycardia, Ventricular; Treatment Outcome | 2010 |
Wide complex tachycardia causing congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Catheter Ablation; Cyclohexane Monoterpenes; Defibrillators, Implantable; Electrocardiography; Female; Heart Failure; Humans; Lisinopril; Metoprolol; Middle Aged; Monoterpenes; Procainamide; Tachycardia; Treatment Outcome | 2011 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Humans; Infant; Infusions, Intraosseous; Infusions, Intravenous; Male; Procainamide; Propranolol; Recurrence; Sotalol; Tachycardia, Supraventricular; Treatment Failure; Vagus Nerve Stimulation | 2012 |
Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Canada; Electric Countershock; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Premedication; Procainamide; Propafenone; Retrospective Studies; Treatment Outcome | 2012 |
Lysosomotropic cationic drugs induce cytostatic and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation.
Topics: Amiodarone; Anticholesteremic Agents; Autophagy; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chloroquine; Cholesterol; Cytostatic Agents; Cytotoxins; Human Umbilical Vein Endothelial Cells; Humans; Hydroxychloroquine; Lidocaine; Lovastatin; Lysosomes; Microtubule-Associated Proteins; Poly (ADP-Ribose) Polymerase-1; Procainamide; Quinacrine | 2016 |
A dolus of i.v. amiodarone.
Topics: Amiodarone; Humans; Procainamide; Tachycardia | 2017 |
Procainamide for shockable rhythm cardiac arrest in the Resuscitation Outcome Consortium.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Procainamide; Retrospective Studies | 2022 |